4538 — Fuso Pharmaceutical Industries Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapNeutral

Annual balance sheet for Fuso Pharmaceutical Industries, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	7,268	7,074	7,347	8,014	5,120
Net Total Accounts Receivable
Net Total Receivables	20,401	21,384	21,152	21,741	24,328
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	38,011	39,533	39,787	43,219	44,947
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	25,449	24,638	23,792	23,763	24,427
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	69,153	69,876	69,334	72,466	75,802
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	25,701	26,763	26,375	28,474	29,650
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	36,851	36,193	34,802	36,817	39,141
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	32,302	33,683	34,532	35,649	36,661
Total Liabilities & Shareholders' Equity	69,153	69,876	69,334	72,466	75,802
Total Common Shares Outstanding